The prognostic values of high CRYAB or p53 expression and high CRYAB and p53 co-expression were verified via Kaplan–Meier survival analysis of DFS and OS in another 103 patients with ovarian cancer (P<0.05; Figure 3A-H). This evidence concerns the gene TP53 and ovarian carcinoma.